Deutsche Bank Downgrades Chewy to Hold, Lowers Price Target to $35
Deutsche Bank analyst Lee Horowitz downgrades Chewy (NYSE:CHWY) from Buy to Hold and lowers the price target from $41 to $35.
Goldman Sachs Downgrades Altimmune to Neutral, Lowers Price Target to $6
Goldman Sachs analyst Corinne Jenkins downgrades Altimmune (NASDAQ:ALT) from Buy to Neutral and lowers the price target from $20 to $6.
Fermium Research Downgrades Univar Solns to Hold, Raises Price Target to $36.15
Fermium Research analyst Frank Mitsch downgrades Univar Solns (NYSE:UNVR) from Buy to Hold and raises the price target from $35 to $36.15.
Moody’s Earlier Downgraded First Republic Bank’s Ratings (Issuer Rating To B2 From Baa1) And Maintains Ratings Under Review For Downgrade
Moody's Investors Service (Moody's) has today downgraded all long-term ratings and assessments of First Republic Bank (First Republic) and maintained the review for downgrade. First Republic's long-term issuer rating and local currency subordinate ratings were downgraded to B2 from Baa1, and preferred stock non-cumulative rating was downgraded to Caa1(hyb) from Baa3(hyb).
Oppenheimer Downgrades DigitalOcean Holdings to Perform, Announces $40 Price Target
Oppenheimer analyst Timothy Horan downgrades DigitalOcean Holdings (NYSE:DOCN) from Outperform to Perform and announces $40 price target.
TD Cowen Downgrades Oak Street Health to Market Perform, Raises Price Target to $39
TD Cowen analyst Gary Taylor downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform and raises the price target from $34 to $39.
SVB Leerink Downgrades Decibel Therapeutics to Market Perform, Lowers Price Target to $2
SVB Leerink analyst Mani Foroohar downgrades Decibel Therapeutics (NASDAQ:DBTX) from Outperform to Market Perform and lowers the price target from $7 to $2.
Compass Point Downgrades Acushnet Hldgs to Neutral, Lowers Price Target to $55
Compass Point analyst Casey Alexander downgrades Acushnet Hldgs (NYSE:GOLF) from Buy to Neutral and lowers the price target from $65 to $55.
Northland Capital Markets Downgrades Luna Innovations to Market Perform, Announces $8 Price Target
Northland Capital Markets analyst Tim Savageaux downgrades Luna Innovations (NASDAQ:LUNA) from Outperform to Market Perform and announces $8 price target.
William Blair Downgrades American Public Education to Market Perform
William Blair analyst Stephen Sheldon downgrades American Public Education (NASDAQ:APEI) from Outperform to Market Perform.